Ultralife Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Michael Manna

Geschäftsführender

US$779.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	48.4%
Amtszeit als Geschäftsführer	1.6yrs
Eigentum des Geschäftsführers	0.1%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	14yrs

Jüngste Management Updates

Recent updates

Ultralife Corporation: Ready To Surge

Apr 22

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Apr 16

Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement

Mar 14

We Think Ultralife Corporation's (NASDAQ:ULBI) CEO Compensation Package Needs To Be Put Under A Microscope

Jul 15

Is Ultralife Corporation (NASDAQ:ULBI) Potentially Undervalued?

Apr 14

The Trends At Ultralife (NASDAQ:ULBI) That You Should Know About

Mar 09

Ultralife Corporation's (NASDAQ:ULBI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 18

Ultralife reports Q4 results

Feb 04

If You Had Bought Ultralife (NASDAQ:ULBI) Stock Five Years Ago, You Could Pocket A 17% Gain Today

Feb 03

What Type Of Shareholders Make Up Ultralife Corporation's (NASDAQ:ULBI) Share Registry?

Jan 14

Are Insiders Buying Ultralife Corporation (NASDAQ:ULBI) Stock?

Dec 30

Is Ultralife (NASDAQ:ULBI) Using Too Much Debt?

Dec 15

Has Ultralife (NASDAQ:ULBI) Got What It Takes To Become A Multi-Bagger?

Dec 02

A Look At Ultralife's (NASDAQ:ULBI) CEO Remuneration

Nov 19

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Michael Manna im Vergleich zu den Einnahmen von Ultralife verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	US$10m
Dec 31 2023	US$779k	US$377k	US$7m
Sep 30 2023	n/a	n/a	US$4m
Jun 30 2023	n/a	n/a	US$3m
Mar 31 2023	n/a	n/a	-US$297k
Dec 31 2022	US$317k	US$241k	-US$119k

Vergütung im Vergleich zum Markt: MichaelDie Gesamtvergütung ($USD779.04K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD1.58M).

Entschädigung vs. Einkommen: MichaelDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Michael Manna (54 yo)

1.6yrs

Amtszeit

US$779,043

Vergütung

Mr. Michael E. Manna serves as President, Chief Executive Officer & Director at Ultralife Corporation since November 22, 2022. He was President of Battery & Energy Products at Ultralife Corporation since S...

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Michael Manna	President	1.6yrs	US$779.04k	0.11% $ 189.8k
Bradford Whitmore	Chair of the Board of Directors	17yrs	US$103.00k	34.19% $ 58.7m
Thomas Saeli	Independent Director	14.3yrs	US$100.42k	0.48% $ 826.4k
Robert Shaw	Independent Director	14yrs	US$99.39k	0.38% $ 648.2k
Janie Goddard	Independent Director	1.3yrs	US$82.79k	0.026% $ 45.3k

14.0yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrener Vorstand: ULBIDie Vorstandsmitglieder sind sehr erfahren ( 13.9 ).

Ultralife Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Ultralife Corporation, Annual General Meeting, Jul 16, 2024

Independent Chairman recently bought US$111k worth of stock

Independent Chairman recently bought US$181k worth of stock

Independent Chairman recently bought US$99k worth of stock

Independent Chairman recently bought US$112k worth of stock

Independent Chairman recently bought US$398k worth of stock

Recent updates

Ultralife Corporation, Annual General Meeting, Jul 16, 2024

Investor sentiment improves as stock rises 17%

Price target decreased by 7.7% to US$12.00

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation: Ready To Surge

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Investor sentiment improves as stock rises 15%

Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share Price

New major risk - Revenue and earnings growth

Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024

Independent Chairman recently bought US$111k worth of stock

Independent Chairman recently bought US$181k worth of stock

Independent Chairman recently bought US$99k worth of stock

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?

Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment improves as stock rises 18%

Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its Capital

Independent Chairman recently bought US$112k worth of stock

Investor sentiment improves as stock rises 27%

Consensus revenue estimates increase by 12%

New major risk - Share price stability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023

Independent Chairman recently bought US$398k worth of stock

Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt

Independent Chairman recently bought US$146k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 19, 2023

Independent Chairman recently bought US$117k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$122k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$279k worth of stock

Ultralife Corporation Announces Executive Changes

Price target increased to US$12.00

Insufficient new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022

Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt

Ultralife secures $7.5M communications systems contract

Independent Chairman recently bought US$158k worth of stock

Independent Chairman recently bought US$467k worth of stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ultralife receives $4.6M communications systems VAA order

Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022

Independent Chairman recently bought US$219k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 20, 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022

Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman recently bought US$245k worth of stock

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates fall by 14%

Investor sentiment improved over the past week

Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million.

Third quarter 2021 earnings released: US$0.036 loss per share (vs US$0.026 profit in 3Q 2020)

Independent Chairman recently bought US$199k worth of stock

Second quarter 2021 earnings released: EPS US$0.051 (vs US$0.10 in 2Q 2020)

We Think Ultralife Corporation's (NASDAQ:ULBI) CEO Compensation Package Needs To Be Put Under A Microscope

Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Defensive Index

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS US$0.042 (vs US$0.067 in 1Q 2020)